Literature DB >> 31030821

Nephrolithiasis.

Laura Mayans1.   

Abstract

Incidence of nephrolithiasis has increased dramatically over the past 30 years, likely due to environmental changes such as dietary habits. Nephrolithiasis presents as acute flank or abdominal pain with nausea and vomiting. Hematuria is present in 90% of cases, but its absence does not rule out nephrolithiasis. Most cases can be managed expectantly as an outpatient with hydration, analgesia, and possibly medications to aide in passage. A metabolic evaluation may be indicated after a second episode of nephrolithiasis in adults or after a first episode in children or those with a family history of nephrolithiasis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dual-energy flank pain; Kidney stones; Nephrolithiasis

Mesh:

Year:  2019        PMID: 31030821     DOI: 10.1016/j.pop.2019.02.001

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  4 in total

1.  Ureteral calculi lithotripsy for single ureteral calculi: can DNN-assisted model help preoperatively predict risk factors for sepsis?

Authors:  Mingzhen Chen; Jiannan Yang; Junlin Lu; Ziling Zhou; Kun Huang; Sihan Zhang; Guanjie Yuan; Qingpeng Zhang; Zhen Li
Journal:  Eur Radiol       Date:  2022-06-22       Impact factor: 5.315

Review 2.  The Molecular Aspect of Nephrolithiasis Development.

Authors:  Paulina Wigner; Radosław Grębowski; Michal Bijak; Janusz Szemraj; Joanna Saluk-Bijak
Journal:  Cells       Date:  2021-07-29       Impact factor: 6.600

3.  Association between tea intake and hospitalized nephrolithiasis in Chinese adults: A case-control study.

Authors:  Yingyu Liu; Shiyuan Bi; Hexiao Li; Jianxiu Shi; Yang Xia; Kaijun Niu; Song Bai
Journal:  Front Nutr       Date:  2022-09-28

Review 4.  Probiotics in the Prevention of the Calcium Oxalate Urolithiasis.

Authors:  Paulina Wigner; Michał Bijak; Joanna Saluk-Bijak
Journal:  Cells       Date:  2022-01-14       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.